Gastroenterology, Hepatology and Nutrition

Andrew H. Talal, MD — professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition — has established a liver biorepository at the University at Buffalo’s Clinical and Translational Science Institute. 

Jeffrey M. Lackner, PsyD, is leading a pilot study to determine whether behavioral self-management of irritable bowel syndrome (IBS) may lead to fundamental changes in the digestive system’s bacterial ecosystem.

During the Department of Medicine’s third annual Research Day, residents and fellows presented the results of their research projects in areas including bronchoscopic lung volume reduction, improvement in hyperlipidemia management and exosomes in stem cell mediated cardiac repair.

Nearly half of all fellowship-bound internal medicine residents in the University at Buffalo’s 2015 class will continue to call Buffalo home.

Males with irritable bowel syndrome (IBS) experience more interpersonal difficulties than do females with the condition, according to research by Jeffrey M. Lackner, PsyD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition. 

Federal approval of new drugs to treat the hepatitis C virus (HCV) represents “a dramatic, positive development for patients,” says University at Buffalo liver disease expert Andrew H. Talal, MD.

University at Buffalo experts in the Division of Gastroenterology, Hepatology and Nutrition are contributing co-authors of HCV Next, the first multidisciplinary publication focused exclusively on the hepatitis C virus.

Research co-authored by Andrew H. Talal, MD, shows that injection drug users who are enrolled in a treatment program want to be educated about hepatitis C virus (HCV) and are willing to be treated.